Phase I / II Gene Therapy Trial of Fanconi anemia patients with a new orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action - EUROFANCOLEN

Project Details

Description

summary not available
StatusFinished
Effective start/end date1/01/1331/12/18

Collaborative partners

  • (lead)
  • Institut Català de la Salut (ICS)
  • Assistance publique - Hôpitaux de Paris
  • Deutsches Krebsforschungszentrum Heildeberg-German Cancer Research Center
  • Généthon. Centre de Recherche et d'applications sur les thérapies géniques
  • Université Paris Diderot, Paris 7 (PARIS7)
  • Servicio Madrileño de Salud (SERMAS)
  • Universitat Autònoma de Barcelona (UAB)
  • University College London (UCL)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.